erlotinib hydrochloride has been researched along with Bronchopulmonary Dysplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, H; Li, J; Li, W; Li, Y; Liu, C; Xie, L; Zhang, Y | 1 |
1 other study(ies) available for erlotinib hydrochloride and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarization.
Topics: Animals; Bronchopulmonary Dysplasia; Cell Movement; CSK Tyrosine-Protein Kinase; ErbB Receptors; Erlotinib Hydrochloride; Female; Lipopolysaccharides; Myofibroblasts; Pulmonary Alveoli; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases | 2016 |